Vascular smooth muscle cell loss, but not neuroinflammation, drives cerebrovascular reactivity impairment in Alzheimer's disease
Alzheimer's & Dementia · 2026-02 · 22 (2)
DOI: 10.1002/alz.71209 ↗Kurz gefasst
Fachartikel in der Zeitschrift Alzheimer's & Dementia, online erschienen am 24.02.2026. Verfasst von Xiuli Yang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA. Hauptthemen laut MEDLINE: Alzheimer Disease, Muscle, Smooth, Vascular, Cerebrovascular Circulation, Myocytes, Smooth Muscle. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIBIB NIH HHS, NIA NIH HHS, National Institute of Biomedical Imaging and Bioengineering.
Themen: Demenz
Abstract (Originalsprache)
INTRODUCTION Cerebrovascular reactivity (CVR) impairment is a key feature of Alzheimer's disease and related dementias (ADRD), but its mechanistic basis remains unclear. This study examined whether vascular smooth muscle cell (VSMC) loss, rather than amyloidosis or neuroinflammation, underlies CVR deficits. METHODS Non‐contrast magnetic resonance imaging (MRI), including phase‐contrast and pseudo‐continuous arterial spin labeling, was performed in mouse models of amyloidosis (five familial Alzheimer's disease mutations [5xFAD]), VSMC degeneration (cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy [CADASIL]), and lipopolysaccharide‐induced neuroinflammation. Characterizations of vascular, amyloid beta, and inflammatory markers were performed for pathological assessment. RESULTS CVR impairment emerged only when VSMC loss was present in CADASIL mice and at older ages in 5xFAD mice (9–12 months). Amyloid beta deposition occurred earlier than VSMC loss or CVR decline. Neuroinflammation primarily altered baseline cerebral blood flow without affecting CVR or VSMC integrity. DISCUSSION These findings identify VSMC degeneration as an important driver of CVR impairment independent of cerebral amyloid angiopathy or inflammation, highlighting vascular integrity as a potential therapeutic target in ADRD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
- F. M. Kirby Research Center for Functional Brain Imaging, Kennedy Krieger Research Institute, Baltimore, Maryland, USA.
- Division of Neurobiology, Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
- The Solomon H. Snyder Department of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
- Department of Biomedical Engineering, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
ORCID-Profile: Zhiliang Wei
Förderung
- NIBIB NIH HHS
- NIA NIH HHS
- National Institute of Biomedical Imaging and Bioengineering
- National Institute on Aging
Zitieren
APA
Yang, X., Li, Y., Yao, M., Bibic, A., Duan, W., Lu, H., & Wei, Z. (2026). Vascular smooth muscle cell loss, but not neuroinflammation, drives cerebrovascular reactivity impairment in Alzheimer's disease. Alzheimer's & Dementia, 22(2). https://doi.org/10.1002/alz.71209
Vancouver
Yang X, Li Y, Yao M, Bibic A, Duan W, Lu H, et al. Vascular smooth muscle cell loss, but not neuroinflammation, drives cerebrovascular reactivity impairment in Alzheimer's disease. Alzheimer's & Dementia. 2026;22(2). doi:10.1002/alz.71209
BibTeX
@article{Yang2026,
author = {Yang, Xiuli and Li, Yuguo and Yao, Minmin and Bibic, Adnan and Duan, Wenzhen and Lu, Hanzhang and Wei, Zhiliang},
title = {Vascular smooth muscle cell loss, but not neuroinflammation, drives cerebrovascular reactivity impairment in Alzheimer's disease},
journal = {Alzheimer's & Dementia},
year = {2026},
volume = {22},
number = {2},
doi = {10.1002/alz.71209}
}
EUVIMED